Mass spectrometric analysis of posttranslational modifi cations (PTMs) and protein–protein interactions (PPIs)

Advances in Experimental Medicine and Biology

Volumn 806, Issue , 2014, Pages 205-235

  Ngounou Wetie, Armand G ^a   Woods, Alisa G ^a   Darie, Costel C ^a  

^a CLARKSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PROTEIN; PROTEOME; TUMOR PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER CELL; CELL TRANSFORMATION; DEVELOPMENT; GENE; HUMAN; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; ANIMAL; GENETICS; METABOLISM; METHODOLOGY; NEOPLASM; PROTEOMICS; REVIEW;

ANIMALS; HUMANS; MASS SPECTROMETRY; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN ISOFORMS; PROTEIN MODIFICATION, TRANSLATIONAL; PROTEOMICS;

EID: 84907424170     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-06068-2_9     Document Type: Article

References (168)

1. Schmutz J et al (2004) Quality assessment of the human genome sequence. Nature 429(6990):365-368
2. Stein L (2001) Genome annotation: from sequence to biology. Nat Rev Genet 2(7):493-503
3. Eisenberg D et al (2000) Protein function in the post-genomic era. Nature 405(6788):823-826
4. Ngounou Wetie AG et al (2013) Investigation of stable and transient protein-protein interactions: past, present and future. Proteomics 13(3-4):538-557
5. Ngounou Wetie AG et al (2014) Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches. Cell Mol Life Sci 71(2):205-228
6. Darie C (2013) Investigation of protein-protein interactions by Blue Native-PAGE & mass spectrometry. Mod Chem Appl 1(3):e111
7. Darie CC, Shetty V, Spellman DS, Zhang G, Xu C, Cardasis HL, Blais S, Fenyo D, Neubert TA (2008) Blue Native PAGE and mass spectrometry analysis of the ephrin stimulationdependent protein-protein interactions in NG108-EphB2 cells. Applications of mass spectrometry in life safety, NATO science for peace and security series. Springer, Düsseldorf, Germany
8. Darie CC, Litscher ES, Wassarman PM (2008) Structure, processing, and polymerization of rainbow trout egg vitelline envelope proteins. Applications of mass spectrometry in life safety, NATO science for peace and security series. Springer, Düsseldorf, Germany
9. Darie CC (2013) Mass spectrometry and its application in life sciences. Aust J Chem 66:1-2
10. Darie CC et al (2006) Studies of the Ndh complex and photosystem II from mesophyll and bundle sheath chloroplasts of the C4-type plant Zea mays. J Plant Physiol 163(8):800-808
11. Darie CC et al (2011) Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry. Proteomics 11(23):4514-4528
12. Byrum S et al (2012) Analysis of stable and transient protein-protein interactions. Methods Mol Biol 833:143-152
13. Sadrzadeh SM, Bozorgmehr J (2004) Haptoglobin phenotypes in health and disorders. Am J Clin Pathol 121(Suppl):S97-S104
14. Bashor CJ et al (2010) Rewiring cells: synthetic biology as a tool to interrogate the organizational principles of living systems. Annu Rev Biophys 39:515-537
15. McNally FJ, Vale RD (1993) Identification of katanin, an ATPase that severs and disassembles stable microtubules. Cell 75(3):419-429
16. Dutcher SK (2001) The tubulin fraternity: alpha to eta. Curr Opin Cell Biol 13(1):49-54
17. Hemmerich P, Schmiedeberg L, Diekmann S (2011) Dynamic as well as stable protein interactions contribute to genome function and maintenance. Chromosome Res 19(1):131-151
18. Sanderson CM (2008) A new way to explore the world of extracellular protein interactions. Genome Res 18(4):517-520
19. DeLano WL (2002) Unraveling hot spots in binding interfaces: progress and challenges. Curr Opin Struct Biol 12(1):14-20
20. Krylov D, Mikhailenko I, Vinson C (1994) A thermodynamic scale for leucine zipper stability and dimerization specificity: e and g interhelical interactions. EMBO J 13(12):2849-2861
21. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408(6810):307-310
22. Ideker T, Sharan R (2008) Protein networks in disease. Genome Res 18(4):644-652
23. Schuster-Bockler B, Bateman A (2008) Protein interactions in human genetic diseases. Genome Biol 9(1):R9
24. Wong JM, Ionescu D, Ingles CJ (2003) Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2. Oncogene 22(1):28-33
25. Jonsson PF, Bates PA (2006) Global topological features of cancer proteins in the human interactome. Bioinformatics 22(18):2291-2297
26. Soler-Lopez M et al (2011) Interactome mapping suggests new mechanistic details underlying Alzheimer's disease. Genome Res 21(3):364-376
27. Rikova K et al (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131(6):1190-1203
28. Manning G et al (2002) Evolution of protein kinase signaling from yeast to man. Trends Biochem Sci 27(10):514-520
29. Deshaies RJ, Joazeiro CA (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78:399-434
30. Ohtsubo K, Marth JD (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126(5):855-867
31. Olsen JV et al (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127(3):635-648
32. Bischoff R, Schluter H (2012) Amino acids: chemistry, functionality and selected nonenzymatic post-translational modifications. J Proteomics 75(8):2275-2296
33. Darie C (2013) Mass spectrometry and proteomics: principle, workflow, challenges and perspectives. Mod Chem Appl 1(2):e105
34. Darie C (2013) Post-translational modification (PTM) proteomics: challenges and perspectives. Mod Chem Appl 1:e114
35. Ngounou Wetie AG et al (2013) Identification of post-translational modifications by mass spectrometry. Aust J Chem 66:734-748
36. Ngounou Wetie AG et al (2013) Automated mass spectrometry-based functional assay for the routine analysis of the secretome. J Lab Autom 18(1):19-29
37. Ngounou Wetie AG et al (2013) Mass spectrometry for the detection of potential psychiatric biomarkers. J Mol Psychiatry 1:8
38. Sokolowska I et al (2012) Disulfide proteomics for identification of extracellular or secreted proteins. Electrophoresis 33(16):2527-2536
39. Sokolowska I et al (2013) Mass spectrometry investigation of glycosylation on the NXS/T sites in recombinant glycoproteins. Biochim Biophys Acta 1834(8):1474-1483
40. Sokolowska I et al (2013) Applications of mass spectrometry in proteomics. Aust J Chem 66:721-733
41. Sokolowska I et al (2013) Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R). Cell Mol Life Sci 70(16):2835-2848
42. Sokolowska I et al (2011) Mass spectrometry for proteomics-based investigation of oxidative stress and heat shock proteins. In: Andreescu S, Hepel M (eds) Oxidative stress: diagnostics, prevention, and therapy. American Chemical Society, Washington, DC
43. Woods AG, Sokolowska I, Darie CC (2012) Identification of consistent alkylation of cysteineless peptides in a proteomics experiment. Biochem Biophys Res Commun 419(2):305-308
44. Woods AG et al (2012) Potential biomarkers in psychiatry: focus on the cholesterol system. J Cell Mol Med 16(6):1184-1195
45. Woods AG et al (2011) Blue native page and mass spectrometry as an approach for the investigation of stable and transient protein-protein interactions. In: Andreescu S, Hepel M (eds) Oxidative stress: diagnostics, prevention, and therapy. American Chemical Society, Washington, DC
46. Olsen JV et al (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3(104):ra3
47. Zhang G et al (2006) Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC). J Proteome Res 5(3):581-588
48. Rinschen MM et al (2010) Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells. Proc Natl Acad Sci U S A 107(8):3882-3887
49. Cantin GT et al (2006) Quantitative phosphoproteomic analysis of the tumor necrosis factor pathway. J Proteome Res 5(1):127-134
50. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57-70
51. Pan C et al (2009) Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions. Mol Cell Proteomics 8(3):443-450
52. Lee J et al (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9(5):391-403
53. Malik R et al (2010) From proteome lists to biological impact-tools and strategies for the analysis of large MS data sets. Proteomics 10(6):1270-1283
54. Finkel T (2011) Signal transduction by reactive oxygen species. J Cell Biol 194(1):7-15
55. Hill BG et al (2010) What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology. J Biol Chem 285(26):19699-19704
56. Higdon A et al (2012) Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem J 442(3):453-464
57. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87(1):315-424
58. Apweiler R, Hermjakob H, Sharon N (1999) On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1473(1):4-8
59. Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631-664
60. Stanley P (2011) Golgi glycosylation. Cold Spring Harb Perspect Biol 3(4):1-13
61. Halim A et al (2011) Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid. Proc Natl Acad Sci U S A 108(29):11848-11853
62. Steentoft C et al (2011) Mining the O-glycoproteome using zinc-finger nucleaseglycoengineered SimpleCell lines. Nat Methods 8(11):977-982
63. Spiro RG (1969) Characterization and quantitative determination of the hydroxylysine-linked carbohydrate units of several collagens. J Biol Chem 244(4):602-612
64. Spiro RG (2002) Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 12(4):43R-56R
65. Reis CA et al (2010) Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol 63(4):322-329
66. Aggarwal S (2010) What's fueling the biotech engine-2009-2010. Nat Biotechnol 28(11):1165-1171
67. Hunt JV, Dean RT, Wolff SP (1988) Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256(1):205-212
68. Smith MA et al (1994) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann N Y Acad Sci 738:447-454
69. Elsholz AK et al (2012) Global impact of protein arginine phosphorylation on the physiology of Bacillus subtilis. Proc Natl Acad Sci U S A 109(19):7451-7456
70. Laub MT, Goulian M (2007) Specificity in two-component signal transduction pathways. Annu Rev Genet 41:121-145
71. Barford D (1996) Molecular mechanisms of the protein serine/threonine phosphatases. Trends Biochem Sci 21(11):407-412
72. Zhang ZY (2002) Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. Annu Rev Pharmacol Toxicol 42:209-234
73. Johnson LN, Barford D (1993) The effects of phosphorylation on the structure and function of proteins. Annu Rev Biophys Biomol Struct 22:199-232
74. Hunter T (2007) The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 28(5):730-738
75. Braconi Quintaje S, Orchard S (2008) The annotation of both human and mouse kinomes in UniProtKB/Swiss-Prot: one small step in manual annotation, one giant leap for full comprehension of genomes. Mol Cell Proteomics 7(8):1409-1419
76. Jackson MD, Denu JM (2001) Molecular reactions of protein phosphatases-insights from structure and chemistry. Chem Rev 101(8):2313-2340
77. Guan KL, Dixon JE (1991) Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J Biol Chem 266(26):17026-17030
78. Paik WK, Paik DC, Kim S (2007) Historical review: the field of protein methylation. Trends Biochem Sci 32(3):146-152
79. Ishikawa Y, Melville DB (1970) The enzymatic alpha-N-methylation of histidine. J Biol Chem 245(22):5967-5973
80. Bedford MT, Clarke SG (2009) Protein arginine methylation in mammals: who, what, and why. Mol Cell 33(1):1-13
81. Wang C et al (2005) A general fluorescence-based coupled assay for S-adenosylmethioninedependent methyltransferases. Biochem Biophys Res Commun 331(1):351-356
82. Erce MA et al (2012) The methylproteome and the intracellular methylation network. Proteomics 12(4-5):564-586
83. Darwanto A et al (2010) A modified "cross-talk" between histone H2B Lys-120 ubiquitination and H3 Lys-79 methylation. J Biol Chem 285(28):21868-21876
84. Haglund K, Dikic I (2005) Ubiquitylation and cell signaling. EMBO J 24(19):3353-3359
85. Pickart CM, Eddins MJ (2004) Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 1695(1-3):55-72
86. Nijman SM et al (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123(5):773-786
87. Bhoj VG, Chen ZJ (2009) Ubiquitylation in innate and adaptive immunity. Nature 458(7237):430-437
88. Manning G et al (2002) The protein kinase complement of the human genome. Science 298(5600):1912-1934
89. Alonso A et al (2004) Protein tyrosine phosphatases in the human genome. Cell 117(6):699-711
90. Shi Y (2009) Serine/threonine phosphatases: mechanism through structure. Cell 139(3):468-484
91. Danielsen JM et al (2011) Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol Cell Proteomics 10(3):M110.003590
92. Jin L et al (2012) Ubiquitin-dependent regulation of COPII coat size and function. Nature 482(7386):495-500
93. Pickart CM (2001) Mechanisms underlying ubiquitination. Annu Rev Biochem 70:503-533
94. Motegi A et al (2008) Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks. Proc Natl Acad Sci U S A 105(34):12411-12416
95. Zhao S et al (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327(5968):1000-1004
96. Wellen KE et al (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324(5930):1076-1080
97. Ganesan A et al (2009) Epigenetic therapy: histone acetylation, DNA methylation and anticancer drug discovery. Curr Cancer Drug Targets 9(8):963-981
98. Li G, Reinberg D (2011) Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev 21(2):175-186
99. Khan SN, Khan AU (2010) Role of histone acetylation in cell physiology and diseases: an update. Clin Chim Acta 411(19-20):1401-1411
100. Sato N et al (2003) Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 63(14):4158-4166
101. Balasubramanyam K et al (2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279(49):51163-51171
102. Aggarwal S et al (2006) Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69(1):195-206
103. Choudhary C et al (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325(5942):834-840
104. Plazas-Mayorca MD et al (2010) Quantitative proteomics reveals direct and indirect alterations in the histone code following methyltransferase knockdown. Mol Biosyst 6(9):1719-1729
105. Sokolowska I et al (2012) Proteomic analysis of plasma membranes isolated from undifferentiated and differentiated HepaRG cells. Proteome Sci 10(1):47
106. Sokolowska I et al (2013) The potential of biomarkers in psychiatry: Focus on proteomics. J Neural Transm 1-10
107. Woods AG et al (2013) Mass spectrometry as a tool for studying autism spectrum disorder. J Mol Psychiatry 1:6
108. Garcia BA (2010) What does the future hold for top down mass spectrometry? J Am Soc Mass Spectrom 21(2):193-202
109. Cannon J et al (2010) High-throughput middle-down analysis using an orbitrap. J Proteome Res 9(8):3886-3890
110. Picotti P, Aebersold R (2012) Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 9(6):555-566
111. Lehmann WD et al (2007) Neutral loss-based phosphopeptide recognition: a collection of caveats. J Proteome Res 6(7):2866-2873
112. Syka JE et al (2004) Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A 101(26):9528-9533
113. Kelleher NL et al (1999) Localization of labile posttranslational modifications by electron capture dissociation: the case of gamma-carboxyglutamic acid. Anal Chem 71(19):4250-4253
114. Good DM et al (2007) Performance characteristics of electron transfer dissociation mass spectrometry. Mol Cell Proteomics 6(11):1942-1951
115. Choudhary C, Mann M (2010) Decoding signalling networks by mass spectrometry-based proteomics. Nat Rev Mol Cell Biol 11(6):427-439
116. Fields S, Song O (1989) A novel genetic system to detect protein-protein interactions. Nature 340(6230):245-246
117. Monti M et al (2005) Interaction proteomics. Biosci Rep 25(1-2):45-56
118. Miernyk JA, Thelen JJ (2008) Biochemical approaches for discovering protein-protein interactions. Plant J 53(4):597-609
119. Berkowitz SA (2006) Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals. AAPS J 8(3):E590-E605
120. Miyashita T (2004) Confocal microscopy for intracellular co-localization of proteins. Methods Mol Biol 261:399-410
121. Berggard T, Linse S, James P (2007) Methods for the detection and analysis of proteinprotein interactions. Proteomics 7(16):2833-2842
122. Jensen ON (2006) Interpreting the protein language using proteomics. Nat Rev Mol Cell Biol 7(6):391-403
123. Schagger H, von Jagow G (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199(2):223-231
124. Schagger H, Cramer WA, von Jagow G (1994) Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis. Anal Biochem 217(2):220-230
125. Darie CC et al (2005) Isolation and structural characterization of the Ndh complex from mesophyll and bundle sheath chloroplasts of Zea mays. FEBS J 272(11):2705-2716
126. Spellman DS et al (2008) Stable isotopic labeling by amino acids in cultured primary neurons: application to brain-derived neurotrophic factor-dependent phosphotyrosine-associated signaling. Mol Cell Proteomics 7(6):1067-1076
127. Schagger H (1995) Native electrophoresis for isolation of mitochondrial oxidative phosphorylation protein complexes. Methods Enzymol 260:190-202
128. Ganem J, Li YT, Henion J (1991) Detection of noncovalent receptor-ligand complexes by mass spectrometry. J Am Chem Soc 113:6294-6296
129. Sakata E et al (2011) The catalytic activity of Ubp6 enhances maturation of the proteasomal regulatory particle. Mol Cell 42(5):637-649
130. Zhou M et al (2008) Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3. Proc Natl Acad Sci U S A 105(47): 18139-18144
131. Lorenzen K et al (2007) Structural biology of RNA polymerase III: mass spectrometry elucidates subcomplex architecture. Structure 15(10):1237-1245
132. Uetrecht C et al (2008) High-resolution mass spectrometry of viral assemblies: molecular composition and stability of dimorphic hepatitis B virus capsids. Proc Natl Acad Sci U S A 105(27):9216-9220
133. Barrera NP et al (2008) Micelles protect membrane complexes from solution to vacuum. Science 321(5886):243-246
134. Barrera NP et al (2009) Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions. Nat Methods 6(8):585-587
135. Xie F et al (2011) Liquid chromatography-mass spectrometry-based quantitative proteomics. J Biol Chem 286(29):25443-25449
136. Filiou MD et al (2012) To label or not to label: applications of quantitative proteomics in neuroscience research. Proteomics 12(4-5):736-747
137. Mann M (2006) Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol 7(12):952-958
138. Gygi SP et al (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17(10):994-999
139. Ross PL et al (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3(12):1154-1169
140. Ong SE et al (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1(5):376-386
141. Oeljeklaus S, Meyer HE, Warscheid B (2009) New dimensions in the study of protein complexes using quantitative mass spectrometry. FEBS Lett 583(11):1674-1683
142. Foster LJ et al (2006) Insulin-dependent interactions of proteins with GLUT4 revealed through stable isotope labeling by amino acids in cell culture (SILAC). J Proteome Res 5(1):64-75
143. Dobreva I et al (2008) Mapping the integrin-linked kinase interactome using SILAC. J Proteome Res 7(4):1740-1749
144. Trinkle-Mulcahy L et al (2006) Repo-Man recruits PP1 gamma to chromatin and is essential for cell viability. J Cell Biol 172(5):679-692
145. Blagoev B et al (2003) A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 21(3):315-318
146. Pflieger D et al (2008) Quantitative proteomic analysis of protein complexes: concurrent identification of interactors and their state of phosphorylation. Mol Cell Proteomics 7(2):326-346
147. Knight ZA et al (2003) Phosphospecific proteolysis for mapping sites of protein phosphorylation. Nat Biotechnol 21(9):1047-1054
148. Oda Y, Nagasu T, Chait BT (2001) Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol 19(4):379-382
149. Wells L et al (2002) Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol Cell Proteomics 1(10):791-804
150. Li W et al (2003) Susceptibility of the hydroxyl groups in serine and threonine to betaelimination/ Michael addition under commonly used moderately high-temperature conditions. Anal Biochem 323(1):94-102
151. Dephoure N et al (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105(31):10762-10767
152. Tan CS et al (2009) Positive selection of tyrosine loss in metazoan evolution. Science 325(5948):1686-1688
153. Zhang K et al (2004) Differentiation between peptides containing acetylated or tri-methylated lysines by mass spectrometry: an application for determining lysine 9 acetylation and methylation of histone H3. Proteomics 4(1):1-10
154. Toda T et al (2010) Proteomic approaches to oxidative protein modifications implicated in the mechanism of aging. Geriatr Gerontol Int 10(Suppl 1):S25-S31
155. Lapko VN, Smith DL, Smith JB (2000) Identification of an artifact in the mass spectrometry of proteins derivatized with iodoacetamide. J Mass Spectrom 35(4):572-575
156. Lundell N, Schreitmuller T (1999) Sample preparation for peptide mapping-a pharmaceutical quality-control perspective. Anal Biochem 266(1):31-47
157. Windsor WT et al (1993) Disulfide bond assignments and secondary structure analysis of human and murine interleukin 10. Biochemistry 32(34):8807-8815
158. Yang Z, Attygalle AB (2007) LC/MS characterization of undesired products formed during iodoacetamide derivatization of sulfhydryl groups of peptides. J Mass Spectrom 42(2): 233-243
159. Michalski A, Cox J, Mann M (2011) More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/ MS. J Proteome Res 10(4):1785-1793
160. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26(12):1367-1372
161. Wu R et al (2011) A large-scale method to measure absolute protein phosphorylation stoichiometries. Nat Methods 8(8):677-683
162. Kool J et al (2011) Studying protein-protein affinity and immobilized ligand-protein affinity interactions using MS-based methods. Anal Bioanal Chem 401(4):1109-1125
163. Bunt J et al (2012) OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells. Int J Cancer 131(2):E21-E32
164. Brewis IA, Brennan P (2010) Proteomics technologies for the global identification and quantification of proteins. Adv Protein Chem Struct Biol 80:1-44
165. Wang F, Pan YC (1991) Structural analyses of proteins electroblotted from native polyacrylamide gels onto polyvinyldiene difluoride membranes. A method for determining the stoichiometry of protein-protein interaction in solution. Anal Biochem 198(2):285-291
166. Wang F et al (1993) Electroblotting proteolytic products from native gel for direct N-terminal sequence analysis: an approach for studying protein-protein interaction. Electrophoresis 14(9):847-851
167. Karger BL, Chu YH, Foret F (1995) Capillary electrophoresis of proteins and nucleic acids. Annu Rev Biophys Biomol Struct 24:579-610
168. Vergnon AL, Chu YH (1999) Electrophoretic methods for studying protein-protein interactions. Methods 19(2):270-277